Study to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a Phase 1/2 Study to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease. This is a multicenter study, which will be conducted in two phases and will enroll up to a total of 42 subjects.
Epistemonikos ID: be40dd1e218360235397befa18e5fa72bc67206d
First added on: May 15, 2024